Achieve Life Sciences Announces Board & Officer Changes
Ticker: ACHV · Form: 8-K · Filed: Sep 11, 2025 · CIK: 949858
| Field | Detail |
|---|---|
| Company | Achieve Life Sciences, Inc. (ACHV) |
| Form Type | 8-K |
| Filed Date | Sep 11, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-governance, officer-director-changes
Related Tickers: ACHV
TL;DR
Achieve Life Sciences is shuffling its board and officers, effective Sept 5, 2025.
AI Summary
Achieve Life Sciences, Inc. announced on September 5, 2025, a series of significant corporate actions. These include the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its officers. The company also reported its principal business address in Bothell, WA, and a secondary address in Vancouver, BC, Canada.
Why It Matters
Changes in board and officer composition can signal shifts in company strategy, operational focus, or financial direction.
Risk Assessment
Risk Level: medium — Changes in leadership and compensatory arrangements can indicate internal restructuring or strategic shifts that may impact future performance.
Key Players & Entities
- Achieve Life Sciences, Inc. (company) — Registrant
- September 5, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Bothell, WA (location) — Principal Business Address
- Vancouver, BC, Canada (location) — Secondary Business Address
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of certain officers and directors but does not specify the exact roles in this section.
Who are the newly elected directors?
The filing states that directors have been elected but does not name them in this section.
What are the key changes in compensatory arrangements for officers?
The filing mentions updates to compensatory arrangements for certain officers but does not detail these changes.
What is the primary business address of Achieve Life Sciences, Inc.?
The primary business address is 22722 29th Drive SE, Suite 100, Bothell, WA 98021.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated September 5, 2025.
Filing Stats: 465 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2025-09-11 17:12:07
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ACHV The Nasdaq Stock Mar
Filing Documents
- achv-20250905.htm (8-K) — 48KB
- 0001193125-25-201418.txt ( ) — 190KB
- achv-20250905.xsd (EX-101.SCH) — 50KB
- achv-20250905_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ACHIEVE LIFE SCIENCES, INC. Date: September 11, 2025 /s/ MARK OKI Mark Oki Chief Financial Officer (Principal Financial Officer)